Methamphetamine fails to alter the noradrenergic integrity of the heart: A comparison with the parkinsonism-inducing neurotoxin MPTP

Riccardo Ruffoli, Paola Soldani, Livia Pasquali, Stefano Ruggieri, Antonio Paparelli, Francesco Fornai

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The chronic use of methamphetamine leads to cardiomyopathy and a nigrostriatal dopamine deficiency that partly mimics what occurs in Parkinson's disease. This study examines the cardiac effects occurring after chronic administration of methamphetamine and parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Despite the similarities concerning the nigrostriatal dopamine denervation, methamphetamine failed to produce chronic norepinephrine depletion in the heart, thus contrasting with what occurs in Parkinson's disease or after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. These data suggest that the chronic cardiovascular effects induced by methamphetamine rely on biochemical changes which differ from those activated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine or during the course of Parkinson's disease.

Original languageEnglish
Title of host publicationAnnals of the New York Academy of Sciences
Pages337-344
Number of pages8
Volume1139
DOIs
Publication statusPublished - Oct 2008

Publication series

NameAnnals of the New York Academy of Sciences
Volume1139
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Methamphetamine
Neurotoxins
Parkinsonian Disorders
Parkinson Disease
Dopamine
Denervation
Cardiomyopathies
Norepinephrine

Keywords

  • Cardiac noradrenergic innervation
  • Methamphetamine
  • MPTP
  • Parkinson's disease
  • Parkinsonian heart

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ruffoli, R., Soldani, P., Pasquali, L., Ruggieri, S., Paparelli, A., & Fornai, F. (2008). Methamphetamine fails to alter the noradrenergic integrity of the heart: A comparison with the parkinsonism-inducing neurotoxin MPTP. In Annals of the New York Academy of Sciences (Vol. 1139, pp. 337-344). (Annals of the New York Academy of Sciences; Vol. 1139). https://doi.org/10.1196/annals.1432.017

Methamphetamine fails to alter the noradrenergic integrity of the heart : A comparison with the parkinsonism-inducing neurotoxin MPTP. / Ruffoli, Riccardo; Soldani, Paola; Pasquali, Livia; Ruggieri, Stefano; Paparelli, Antonio; Fornai, Francesco.

Annals of the New York Academy of Sciences. Vol. 1139 2008. p. 337-344 (Annals of the New York Academy of Sciences; Vol. 1139).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ruffoli, R, Soldani, P, Pasquali, L, Ruggieri, S, Paparelli, A & Fornai, F 2008, Methamphetamine fails to alter the noradrenergic integrity of the heart: A comparison with the parkinsonism-inducing neurotoxin MPTP. in Annals of the New York Academy of Sciences. vol. 1139, Annals of the New York Academy of Sciences, vol. 1139, pp. 337-344. https://doi.org/10.1196/annals.1432.017
Ruffoli R, Soldani P, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Methamphetamine fails to alter the noradrenergic integrity of the heart: A comparison with the parkinsonism-inducing neurotoxin MPTP. In Annals of the New York Academy of Sciences. Vol. 1139. 2008. p. 337-344. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1432.017
Ruffoli, Riccardo ; Soldani, Paola ; Pasquali, Livia ; Ruggieri, Stefano ; Paparelli, Antonio ; Fornai, Francesco. / Methamphetamine fails to alter the noradrenergic integrity of the heart : A comparison with the parkinsonism-inducing neurotoxin MPTP. Annals of the New York Academy of Sciences. Vol. 1139 2008. pp. 337-344 (Annals of the New York Academy of Sciences).
@inproceedings{5cf5d4a0d939406c9e9f1d897a77775e,
title = "Methamphetamine fails to alter the noradrenergic integrity of the heart: A comparison with the parkinsonism-inducing neurotoxin MPTP",
abstract = "The chronic use of methamphetamine leads to cardiomyopathy and a nigrostriatal dopamine deficiency that partly mimics what occurs in Parkinson's disease. This study examines the cardiac effects occurring after chronic administration of methamphetamine and parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Despite the similarities concerning the nigrostriatal dopamine denervation, methamphetamine failed to produce chronic norepinephrine depletion in the heart, thus contrasting with what occurs in Parkinson's disease or after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. These data suggest that the chronic cardiovascular effects induced by methamphetamine rely on biochemical changes which differ from those activated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine or during the course of Parkinson's disease.",
keywords = "Cardiac noradrenergic innervation, Methamphetamine, MPTP, Parkinson's disease, Parkinsonian heart",
author = "Riccardo Ruffoli and Paola Soldani and Livia Pasquali and Stefano Ruggieri and Antonio Paparelli and Francesco Fornai",
year = "2008",
month = "10",
doi = "10.1196/annals.1432.017",
language = "English",
isbn = "9781573317184",
volume = "1139",
series = "Annals of the New York Academy of Sciences",
pages = "337--344",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Methamphetamine fails to alter the noradrenergic integrity of the heart

T2 - A comparison with the parkinsonism-inducing neurotoxin MPTP

AU - Ruffoli, Riccardo

AU - Soldani, Paola

AU - Pasquali, Livia

AU - Ruggieri, Stefano

AU - Paparelli, Antonio

AU - Fornai, Francesco

PY - 2008/10

Y1 - 2008/10

N2 - The chronic use of methamphetamine leads to cardiomyopathy and a nigrostriatal dopamine deficiency that partly mimics what occurs in Parkinson's disease. This study examines the cardiac effects occurring after chronic administration of methamphetamine and parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Despite the similarities concerning the nigrostriatal dopamine denervation, methamphetamine failed to produce chronic norepinephrine depletion in the heart, thus contrasting with what occurs in Parkinson's disease or after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. These data suggest that the chronic cardiovascular effects induced by methamphetamine rely on biochemical changes which differ from those activated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine or during the course of Parkinson's disease.

AB - The chronic use of methamphetamine leads to cardiomyopathy and a nigrostriatal dopamine deficiency that partly mimics what occurs in Parkinson's disease. This study examines the cardiac effects occurring after chronic administration of methamphetamine and parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Despite the similarities concerning the nigrostriatal dopamine denervation, methamphetamine failed to produce chronic norepinephrine depletion in the heart, thus contrasting with what occurs in Parkinson's disease or after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. These data suggest that the chronic cardiovascular effects induced by methamphetamine rely on biochemical changes which differ from those activated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine or during the course of Parkinson's disease.

KW - Cardiac noradrenergic innervation

KW - Methamphetamine

KW - MPTP

KW - Parkinson's disease

KW - Parkinsonian heart

UR - http://www.scopus.com/inward/record.url?scp=53549087549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53549087549&partnerID=8YFLogxK

U2 - 10.1196/annals.1432.017

DO - 10.1196/annals.1432.017

M3 - Conference contribution

C2 - 18991879

AN - SCOPUS:53549087549

SN - 9781573317184

VL - 1139

T3 - Annals of the New York Academy of Sciences

SP - 337

EP - 344

BT - Annals of the New York Academy of Sciences

ER -